1. Home
  2. COHN vs ENLV Comparison

COHN vs ENLV Comparison

Compare COHN & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COHN
  • ENLV
  • Stock Information
  • Founded
  • COHN 1999
  • ENLV 2005
  • Country
  • COHN United States
  • ENLV Israel
  • Employees
  • COHN N/A
  • ENLV N/A
  • Industry
  • COHN Investment Bankers/Brokers/Service
  • ENLV Biotechnology: Pharmaceutical Preparations
  • Sector
  • COHN Finance
  • ENLV Health Care
  • Exchange
  • COHN Nasdaq
  • ENLV Nasdaq
  • Market Cap
  • COHN 21.6M
  • ENLV 25.5M
  • IPO Year
  • COHN N/A
  • ENLV 1995
  • Fundamental
  • Price
  • COHN $11.27
  • ENLV $1.02
  • Analyst Decision
  • COHN
  • ENLV Strong Buy
  • Analyst Count
  • COHN 0
  • ENLV 2
  • Target Price
  • COHN N/A
  • ENLV $10.00
  • AVG Volume (30 Days)
  • COHN 4.5K
  • ENLV 176.9K
  • Earning Date
  • COHN 11-03-2025
  • ENLV 08-29-2025
  • Dividend Yield
  • COHN 9.09%
  • ENLV N/A
  • EPS Growth
  • COHN 37.63
  • ENLV N/A
  • EPS
  • COHN 1.14
  • ENLV N/A
  • Revenue
  • COHN $133,173,000.00
  • ENLV N/A
  • Revenue This Year
  • COHN N/A
  • ENLV N/A
  • Revenue Next Year
  • COHN N/A
  • ENLV N/A
  • P/E Ratio
  • COHN $9.66
  • ENLV N/A
  • Revenue Growth
  • COHN 78.63
  • ENLV N/A
  • 52 Week Low
  • COHN $6.10
  • ENLV $0.81
  • 52 Week High
  • COHN $13.25
  • ENLV $2.10
  • Technical
  • Relative Strength Index (RSI)
  • COHN 45.71
  • ENLV 38.42
  • Support Level
  • COHN $10.90
  • ENLV $1.02
  • Resistance Level
  • COHN $11.49
  • ENLV $1.08
  • Average True Range (ATR)
  • COHN 0.34
  • ENLV 0.04
  • MACD
  • COHN -0.05
  • ENLV 0.01
  • Stochastic Oscillator
  • COHN 38.61
  • ENLV 16.67

About COHN Cohen & Company Inc.

Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: